Scribd
Upload
47 views5 pages

COVID-19 in 2 Persons With Mild Upper Respiratory Symptoms On A Cruise Ship, Japan

This document summarizes the clinical laboratory results of two patients who tested positive for COVID-19 while working on a cruise ship in Japan. Patient 1's results on day 6 showed slightly elevated white blood cell and red blood cell counts as well as glucose levels. Patient 2's results on day 7 showed elevated red blood cell, monocyte, and glucose counts along with slightly low phosphate levels. Chest x-rays and photos of patient 2 also showed mild symptoms.

Uploaded by

dhaya
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
47 views5 pages

COVID-19 in 2 Persons With Mild Upper Respiratory Symptoms On A Cruise Ship, Japan

This document summarizes the clinical laboratory results of two patients who tested positive for COVID-19 while working on a cruise ship in Japan. Patient 1's results on day 6 showed slightly elevated white blood cell and red blood cell counts as well as glucose levels. Patient 2's results on day 7 showed elevated red blood cell, monocyte, and glucose counts along with slightly low phosphate levels. Chest x-rays and photos of patient 2 also showed mild symptoms.

Uploaded by

dhaya
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 5

Article DOI: https://doi.org/10.3201/eid2606.

200452

COVID-19 in 2 Persons with Mild Upper


Respiratory Symptoms on a Cruise Ship,
Japan

Appendix

Appendix Table 1. Clinical laboratory results at time of hospital admission, day 6 post illness onset, for case 1 of 2019 novel

coronavirus (COVID-19) diagnosed in a woman who worked on a cruise ship

Measure Patient values Reference range


Leukocyte count/μL 3,900 3,300–8,600
Red blood cell count/μL 5,210,000* 3,860,000–4,920,000
Neutrophils, % 56.9 38.3–74.7
Lymphocytes, % 32.1 21.2–51.0
Monocytes, % 6.0 2.7–8.0
Eosinophils, % 4.7 0.2–8.4
Basophils, % 0.3 0.2–2.0
Absolute neutrophil count/μL 2,219
Absolute lymphocyte count/μL 1,252
Hemoglobin, g/dL 14.6 11.6–14.8
Hematocrit, % 43.0 35.1–44.4
Platelets/μL 159,000 158,000–348,000
Sodium, mmol/L 140 138–145
Potassium, mmol/L 3.9 3.6–4.8
Chloride, mmol/L 106 101–108
Calcium, mg/dL 9.4 8.8–10.1
Phosphate, mg/dL 3.8 2.7–4.6
Total protein, g/dL 7.7 6.6–8.1
Albumin, g/dL 4.5 4.1–5.1
Alanine aminotransferase, U/L 18 7–23
Aspartate aminotransferase, U/L 17 13–30
Gamma-glutamyl transpeptidase, U/L 17 9–32
Total bilirubin, mg/dL 3.2 0.4–1.5
Amylase, mmol/L 67 44–132
Blood urea nitrogen, mg/dL 6† 8–20
Creatinine, mg/dL 0.56 0.46–0.79

Page 1 of 5
Measure Patient values Reference range
Lactate dehydrogenase, U/L 181 124–222
Creatine kinase, U/L 69 41–153
Glucose, mg/dL 112* 73–109
Hemoglobin A1c, % 5.6 4.9–6.0
C-reactive protein, mg/dL 0.12 0.0–0.14
Prothrombin time, s 11.9
International normalized ratio 0.94
Activated partial thromboplastin time, s 31.5 25–35
Fibrinogen, mg/dL 250 220–410
Antistreptolysin O, IU/mL 97 <239
*Value is above the reference range.

Appendix Table 2. Clinical laboratory results at time of hospital admission, day 7 post illness onset, for case 2 of 2019 novel

coronavirus (COVID-19) diagnosed in a man who worked on a cruise ship

Measure Patient values Reference range


Leukocyte count/μL 5,200 3,300–8,600
Red blood cell count/μL 6,490,000* 4,350,000–5,550,000
Neutrophils,% 41.7 38.3–74.7
Lymphocytes, % 44.1 21.2–51.0
Monocytes, % 9.6* 2.7–8.0
Eosinophils, % 3.1 0.2–8.4
Basophils, % 1.5 0.2–2.0
Absolute neutrophil count/μL 2,168
Absolute lymphocyte count/μL 2,293
Hemoglobin, g/dL 15.9 13.7–16.8
Hematocrit, % 48.4 40.7–50.1
Platelets/μL 291,000 158,000–348,000
Sodium, mmol/L 139 138–145
Potassium, mmol/L 3.9 3.6–4.8
Chloride, mmol/L 105 101–108
Calcium, mg/dL 9.5 8.8–10.1
Phosphate. mg/dL 2.2† 2.7–4.6
Total protein, g/dL 7.7 6.6–8.1
Albumin, g/dL 4.7 4.1–5.1
Alanine aminotransferase, U/L 41 10–42
Aspartate aminotransferase, U/L 27 13–30
Gamma-glutamyl transpeptidase, U/L 57 13–64
Total bilirubin, mg/dL 0.4 0.4–1.5
Amylase, mmol/L 97 44–132
Blood urea nitrogen, mg/dL 11 8–20
Creatinine, mg/dL 0.84 0.46–0.79

Page 2 of 5
Measure Patient values Reference range
Lactate dehydrogenase, U/L 170 124–222
Creatine kinase, U/L 166 41–153
Glucose, mg/dL 115* 73–109
Hemoglobin A1c, % 6.0 4.9–6.0
C-reactive protein, mg/dL 0.06 0.0–0.14
Prothrombin time, s 11.6
International normalized ratio 0.92
Activated partial thromboplastin time, s 31.5 25–35
Fibrinogen, mg/dL 258 220–410
Antistreptolysin O, IU/mL 69 <239
*Value is above reference range.

Page 3 of 5
Appendix Figure 1. Anteroposterior chest radiographs of 2 patients with mild upper respiratory

symptoms who tested positive for 2019 novel coronavirus (COVID-19). A) Case-patient 1 at day 6 post

illness onset. B) Case-patient 2 at day 7 post illness onset.

Page 4 of 5
Appendix Figure 2. Throat redness of case-patient 2, a 27-year-old man with mild upper respiratory

symptoms who tested positive for 2019 novel coronavirus (COVID-19).

Page 5 of 5

You might also like